Comparison between sirolimus- and paclitaxel-eluting stents for the treatment of chronic total occlusions

Journal of Invasive Cardiology

Volumn 18, Issue 5, 2006, Pages 205-208

  Jang, Jae Sik ^a   Hong, Myeong Ki ^a   Lee, Cheol Whan ^a   Park, Duk Woo ^a   Lee, Bong Ki ^a   Kim, Young Hak ^a   Han, Ki Hoon ^a   Kim, Jae Joong ^a   Park, Seong Wook ^a   Park, Seung Jung ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CHRONIC TOTAL CORONARY ARTERY OCCLUSION; CORONARY STENT; DEATH; DISEASE FREE SURVIVAL; DRUG ELUTING STENT; EVALUATION; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RESTENOSIS; SUDDEN DEATH; SURVIVAL RATE; THROMBOSIS; CHRONIC DISEASE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; HEART DISEASE; HOSPITAL PATIENT; MIDDLE AGED; MORTALITY; RADIOGRAPHY; RETROSPECTIVE STUDY; STENT; SURVIVAL; TREATMENT OUTCOME;

ADULT; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; INPATIENTS; MALE; MIDDLE AGED; PACLITAXEL; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33745001772     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Puma JA, Sketch MH Jr, Tcheng JE, et al. Percutaneous revascularization of chronic coronary occlusions: An overview. J Am Coll Cardiol 1995;26:1-11.
2. Hamburger JN, Gijsbers GH, Ozaki Y, et al. Recanalization of chronic total coronary occlusion using a laser guidewire: A pilot study. J Am Coll Cardiol 1997;30:649-656.
3. Gruberg L, Mehran R, Dangas G, et al. Effect of plaque debulking and stenting on short- and long-term outcomes after revascularization of chronic total occlusions. J Am Coll Cardiol 2000;35:151-156.
4. Sirnes PA, Golf S, Myreng Y, et al. Stenting in chronic coronary occlusion (SICCO): A randomized, controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996;28:1444-1451.
5. Rubartelli P, Niccoli L, Verna E, et al. Stent implantation versus balloon angioplasty in chronic coronary occlusions: Results from the Gissoc Trial (gruppo italiano di studio sullo stent nelle occlusioni coronariche). J Am Coll Cardiol 1998;32:90-96.
6. Buller CE, Dzavik V, Carere RG, et al. Primary stenting versus balloon angioplasty in occluded coronary arteries: The Total Occlusion Study of Canada (TOSCA). Circulation 1999;100:236-242.
7. Lotan C, Rozenman Y, Hendler A, et al. Stents in total occlusion for restenosis prevention: The multicentre randomized STOP study. The Israeli Working Group for Interventional Cardiology. Eur Heart J 2000;21:1960-1966.
8. Höher M, Wöhrle J, Grebe OC, et al. A randomized trial of elective stenting after balloon recanalization of chronic total occlusions. J Am Coll Cardiol 1999;34:722-729.
9. Suttorp MJ, Mast EG, Plokker HW, et al. Primary coronary stenting after successful balloon angioplasty of chronic total occlusions: A single-center experience. Am Heart J 1998;135:318-322.
10. Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-up. Circulation 2001;104:2007-2011.
11. Morice MC, Serruys PW, Sousa JE, et al. RAVEL study group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780.
12. Moses JW, Leon MB, Popma JJ, et al. SIRIUS investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
13. Schofer J, Schlutter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003;362:1093-1099.
14. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
15. Hoye A, Tanabe K, Lemos PA, et al. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. J Am Coll Cardiol 2004;43:1954-1958.
16. Werner GS, Krack A, Schwarz G, et al. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. J Am Coll Cardiol 2004;44:2301-2306.
17. Nakamura S, Muthusamy TS, Bae JH, et al. Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusions. Am J Cardiol 2005;95:161-166.
18. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: Phase I findings. N Engl J Med 1985;312:932-936.
19. Serruys PW, Hamburger JN, Koolen JJ, et al. Total occlusion trial with angioplasty by using laser guidewire: The TOTAL trial. Eur Heart J 2002;21:1797-1805.
20. Choi SW, Lee CW, Hong MK, et al. Clinical and angiographic follow-up after long versus short stenting in unselected chronic coronary occlusions. Clin Cardiol 2003;26:265-268.
21. Violaris AG, Melkert R, Serruys PW. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis. Circulation 1995;91:2140-2150.
22. Berger PB, Holmes DR Jr, Ohman EM, et al. Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR). J Am Coll Cardiol 1996;27:1-7.
23. Finci L, Meier B, Favre J, et al. Long-term results of successful and failed angioplasty for chronic total coronary arterial occlusion. Am J Cardiol 1990;66:660-662.
24. Rambaldi R, Hamburger JN, Geleijnse ML, et al. Early recovery of wall motion abnormalities after recanalization of chronic totally occluded coronary arteries: A dobutamine echocardiographic, prospective, single-center experience. Am Heart J 1998;136:831-836.
25. Sirnes PA, Myreng Y, Mølstad P, et al. Improvement in left ventricular ejection fraction and wall motion after successful recanalization of chronic coronary occlusions. Eur Heart J 1998;19:273-281.
26. Ellis CJ, French JK, White HD. Coronary artery patency and survival in clinical trials. J Thromb Thrombolysis 1997;4:239-250.
27. Califf RM. The GUSTO trial and the open artery theory. Eur Heart J 1997;18(Suppl F):F2-10.
28. Kastrati A, Schomig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997;30:1428-1436.
29. Rogers CD. Drug-eluting stents: Clinical perspectives on drug and design differences. Rev Cardiovasc Med 2005;6:S3-S12.
30. Perin EC. Choosing a drug-eluting stent: A comparison between CYPHER and TAXUS. Rev Cardiovasc Med 2005;6:S13-S21.
31. Kastrati A, Mehilli J, von Beckerath N, et al. ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs. balloon angioplasty for prevention of recurrences in patients with coronary instent restenosis: A randomized controlled trial. JAMA 2005;293:165-171.
32. Dibra A, Kastrati A, Mehilli J, et al. ISAR-DIABETES Study Investigators. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005;353:663-670.
33. Windecker S, Remondino A, Eberli FR, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 2005;353:653-662.